MDK and hepatocellular carcinoma: MDK is definitely a molecule of interest, as its use clearly offers certain advantages, such as the ability to diagnose early HCC, the ability to differentiate between HCC patients and normal individuals or patients with other liver pathologies, the ability to predict recurrence, and the ability to monitor disease progression and treatment response [9].